By InvitationNot Applicable

Control of Assistive Devices Via Brain-Computer Interface Technology

United States3 participantsStarted 2024-11-25

Plain-language summary

The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study (NCT06429735) using the N1 Implant to control various assistive devices. The main goal is to determine whether participants can successfully modulate their brain activity to control devices, such as an Assistive Robotic Arm (ARA). This study will assess the effectiveness, consistency, and safety of neural control using the ARA and other assistive devices.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Continued enrollment in the PRIME Study. * Implanted with the N1 Implant. Exclusion Criteria: * Explantation or deactivation of the N1 Implant. * Insufficient N1 Implant BCI performance demonstrated. * Lack of a suitable physical space to perform research sessions. * Any condition which, in the opinion of the Investigator, would compromise the candidate's ability to safely participate in the study.

What they're measuring

Ability of participants to modulate brain activity for controlling an assistive device via the N1 Implant.

Timeframe: 3-months following first use of the assistive device

Trial details

NCT IDNCT06710626

SponsorNeuralink Corp

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2031-05-25

View on ClinicalTrials.gov More Tetraplegia/Tetraparesis trials